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Abstract Loss of P450 during the early hours of monolayer
formation is known to be the more serious limitation of primary
cultured hepatocytes as an adequate model for the study of drug
metabolism, toxicity and P450 induction. This study reports that
endogenous nitric oxide (NO) formation is activated shortly after
isolation by the classical collagenase-based liver perfusion
methods. Both rapid P450 loss and aerobic mitochondrial energy
metabolism impairment ^ with subsequent changes on glucose
metabolism ^ are directly related to the high local generation of
the radical at this stage. These effects can be reverted by the sole
addition of NO biosynthesis inhibitors during liver perfusion and
early culture hours, which allows catalytically active P450 to be
preserved at levels close to those of the intact liver.
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1. Introduction
Rapid loss of P450 during the ¢rst hours of hepatocyte
culture has for a long time been identi¢ed as the main limi-
tation of this model for the study of drug biotransformation,
toxicity and P450 induction. The early and quick decay of
P450 is not an artifact nor re£ects a generalized loss of the
adult hepatocyte phenotype [1^3], appearing more an adapta-
tive response to the in vitro culture environment. Accordingly
(for review see [3]), the main approaches to improve mainte-
nance of P450 protein and activity in rat liver cell cultures
have pointed to rede¢nition of the culture medium (addition
of nutrients, hormones, antioxidants, haem synthesis precur-
sors, P450 ligands or inducers), culture support modi¢cation
as well as the use of di¡erent coculture systems [4,5]. How-
ever, it appears that in cultured cells P450 can hardly be
preserved to the level found in the intact liver: by 24 h in
standard culture conditions, hepatocytes have already lost
80^90% of their initial P450 content, and only about 50% of
the liver in vivo P450 can be preserved in the best conditions
described (i.e. early exposure to speci¢c P450 inducers or co-
culture). The current view is that P450 loss may well be the
result of enhanced (and generalized) hemoprotein degradation
at this stage of culture together with a failure of hepatocytes
to re-synthesize P450 at adequate rates [3] ; but the mechanism
underlying these e¡ects still remains poorly de¢ned.
In a previous article [6] we reported that other signi¢cant
metabolic changes consistently occur in rat hepatocytes soon
after cell plating: high glycolytic rates together with a rapid
switch to glycogenolysis, a metabolic pattern re£ecting that of
the liver cells under hypoxia. Hence, this study was conducted
to further characterize the mechanism involved in rat hepato-
cyte phenotypic changes at the stages of monolayer develop-
ment, aiming to de¢ne better conditions to improve drug-me-
tabolizing system expression in culture. Results show that
massive nitric oxide (NO) formation is activated upon hepa-
tocyte isolation through the classical collagenase-based meth-
od. NO generation represents in fact a key factor to explain
both the quick P450 loss and the aerobic mitochondrial func-
tion impairment that ultimately explains glucose metabolism
changes resembling hypoxia. Early loss of P450 in rat hepa-
tocyte cultures can thus simply be avoided by the sole addi-
tion of NO biosynthesis inhibitors during liver perfusion
and/or the early culture hours which allows preservation of
catalytically active P450 levels close to those of the intact
liver.
2. Materials and methods
2.1. Cell isolation and culture
Hepatocytes were isolated from fed male Sprague-Dawley rats
(180^250 g) by reversed liver perfusion with collagenase (Boehringer
Mannheim) and cultured on ¢bronectin-coated dishes in a 5% CO2
humidi¢ed atmosphere, as described [6,7]. Culture medium was Ham’s
F12 (containing 10 mM glucose and 1 mM arginine) supplemented
with antibiotics, 0.2% bovine serum albumin, 1038 M insulin and 2%
calf serum (Gibco). NO biosynthesis inhibitors were also added as
indicated. Unattached cells were removed by changing the medium
1 h after plating. Cell viability (cell suspensions and monolayers) was
assessed by the trypan blue dye exclusion test and always exceeded
95% in the experiments reported.
2.2. Determination of P450 content and activity
Total P450 was assayed [8] in microsomes from rat liver samples,
freshly isolated cells or hepatocyte monolayers frozen under liquid N2
(stored at 380‡C). Microsomal fractions were obtained by centrifu-
gation (100 000Ug for 90 min) of the S9 fractions from crude homog-
enates previously obtained through sonication (5^10 mg cell protein/
ml in ice-cold 0.1 M potassium phosphate/1 mM EDTA, pH 7.4).
Microsomal pellets were gently resuspended in a 50 mM Tris-HCl/
20% glycerol bu¡er (pH 7.4) and stored at 320‡C until P450 content
and activity determination. CYP 2C11 activity was assayed as the rate
of tienilic (TA) 5-hydroxylation in conditions of maximal initial rate,
as described previously [9,10]. Protein content (total cellular or micro-
somal fractions) was determined by the Lowry procedure.
2.3. Determination of metabolites
Glycogen, ATP, ADP, AMP content and glycolytic activity (as
lactate released to the medium) were determined by standard proce-
dures as previously detailed [6]. Glycogen content of monolayers was
also visualized cytochemically as PAS-positive material [11]. NO32 and
nitrites (NO32 NO33 ) in the medium were determined by chemilumi-
nescence [12].
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2.4. Statistical analysis
Experiments were performed in at least 3 di¡erent cultures with 3^4
plates per variable. Statistical analysis was done by the Student’s t-
test.
3. Results
Experiments were performed in very simple culture condi-
tions, expressly avoiding supplementation with hormones and/
or e¡ectors, or with complex culture substrata, known to con-
tribute to a better preservation of P450 in cultured liver cells.
3.1. Metabolic pattern of rat hepatocytes at the early stages
of culture
Fig. 1A shows the quick and early P450 loss that character-
izes rat hepatocytes upon culture in routine basal conditions;
6 h after cell plating, P450 content represents less than 50% of
initial and by 24 h total P450 levels are less than 20% of that
determined in the intact liver. In this same period, as shown
(Fig. 1B), hepatocytes also exhibit high glycolytic rates (14^30
nmol lactate/min/mg cell protein for the ¢rst 3^4 h, depending
on the culture) that are close to the maximal theoretical gly-
colytic £ux as estimated by Hue [13]. Lactate in the culture
medium stabilizes at around 2 mM, leading to signi¢cant acid-
i¢cation. Glycogenolysis is also unexpectedly activated soon
after cell plating (Fig. 1C) in spite of the fact that hepatocytes
are isolated from fed animals and cultured without exposure
to glycogen phosphorylase-activating hormones. Glycogen de-
pletion was maximal during the ¢rst 6 h and ^ after a tran-
sient insulin e¡ect ^ proceeded at similar rates whether insulin
was present or not (4^5 nmol glucose/min/mg cell protein).
Thus, by 24 h of culture glycogen stores of hepatocytes (50^
200 nmol glucose/mg cell protein) re£ect those of livers from
fasted rats. Analysis of the cell energy status at this stage
shows (Fig. 1D) that AMP is also sharply increasing as a
function of time so that by only 3 h it reaches values 4-fold
higher than initial, decreasing gradually thereafter. Early
changes in the AMP content (a major signal of anoxia) paral-
lel early changes in the adenine nucleotide content (Fig. 1D).
ATP is relatively stable (or slightly diminishes) but ADP levels
signi¢cantly increase by only 2 h of culture; consequently, the
ATP/ADP ratio of hepatocytes signi¢cantly decreases in
short-term culture from 4.3 (in freshly isolated cells) to 2.4
as determined by 5 h of culture. These changes are, however,
reversible (not shown) and 24 h later, lactate production rates,
ATP, ADP and AMP levels have returned to basal values
while loss of glycogen and P450 is irreversible.
3.2. Activation of NO formation in short-term cultures
NO production (indicated by the accumulation of nitrite in
the medium) is activated soon after hepatocyte plating in spite
of the fact that cells are isolated from control animals unin-
duced for inducible nitric oxide synthase (iNOS) (Fig. 2).
Thus, by 24 h of culture nitrite in the medium is about 50
WM. Ham’s F12 medium does contain 1 mM L-arginine, well
above the Km for arginine (5^10 WM) as described for all the
characterized NOS isoforms [14]. This was considered when
NOS inhibitors were included in the medium. NO formation
could be thus e⁄ciently blocked by the addition of adequate
amounts of known NO biosynthesis inhibitors, like NG-L-ar-
ginine methyl ester (L-NAME) (Fig. 2).
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Fig. 1. Evolution of P450 (A), lactate production (B), glycogen (C)
and adenine nucleotides (D) in short-term culture. Hepatocytes were
cultured in standard medium containing (closed symbols) or not
(open circles, C) 1038 M insulin. P450 (A: b), glycogen (C: F,E)
and adenine nucleotides (D: ATP S, ADP 8 and AMP *) were as-
sayed in cell fractions while glycolysis (B: R) was estimated as lac-
tate accumulation in the medium. Initial values (100%) for ATP,
ADP and AMP are 11.0 þ 1.1, 2.55 þ 0.25 and 0.17 þ 0.02 nmol/mg
cell protein, respectively. Results are the mean þ S.E.M., n = 4 di¡er-
ent cultures.
Fig. 2. Time-course of endogenous NO formation. Cells were cul-
tured in standard medium containing (b) or not (a) 1 mM L-
NAME that was added with the ¢rst medium renewal (1 h after
plating). Data are the mean þ S.D. of 4 dishes from one representa-
tive culture out of three.
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3.3. Activation of NO production is directly involved
in the early P450 loss and the metabolic impairment
of hepatocytes observed in short-term cultures
Inhibition of NO biosynthesis through addition of 1 mM L-
NAME to the culture medium e⁄ciently blocks the quick
decay of P450 content (Fig. 3A). This results in a dose-de-
pendent increase of the P450 level determined after 24 h of
culture in the presence of increasing amounts of L-NAME
(Fig. 3B). Correlation between P450 levels and NO32 concen-
tration in the medium showed a logarithmic pattern (Fig. 3C)
where maximal decrease of P450 is achieved when nitrite in
the medium reaches a mean value of about 10 WM (already
found by 6 h of culture in standard conditions).
Activation of endogenous NO synthesis seems to be a very
early event upon cell isolation since inhibition of NO forma-
tion during only the liver perfusion stage (Fig. 3D) is enough
to partially prevent the early P450 loss showed by control
cultures and allows hepatocytes to retain more than 40% of
their initial P450 by 24 h of culture. Best results are, however,
obtained when 1 mM L-NAME is also present as a compo-
nent of the culture medium for the ¢rst 24 h, which results in
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Fig. 3. E¡ect of the inhibition of NO biosynthesis on total P450
content of hepatocytes in short-term culture. A: Time-course of
P450 levels in hepatocytes isolated in standard conditions and cul-
tured in the presence (b) or absence (a) of 1 mM L-NAME. The in-
hibitor was added with the ¢rst medium renewal (1 h after plating).
Data are mean þ S.D. of 4 dishes from one out of three similar ex-
periments. 100% value (P450 content in freshly isolated cells) is
317.8 þ 17.6 pmol/mg microsomal protein. B: Dose-dependent e¡ect
of L-NAME on P450 recovery by 24 h of culture. Experimental con-
ditions were equivalent to A, except that di¡erent L-NAME concen-
trations were used. Statistical signi¢cance was P6 0.001 for the
three L-NAME variables vs. control (0 mM L-NAME), and P6 0.01
for 1 mM vs. 2 mM L-NAME. C: Correlation of microsomal P450
content to endogenous NO formation (indicated by [NO32 ] in the
medium). Both were determined in parallel for the same plates in
hepatocytes cultured for di¡erent times in the presence of variable
amounts of L-NAME. Data correspond to four di¡erent cultures.
D: Time-course evolution of total P450 in hepatocytes isolated in
the presence of 1 mM L-NAME and subsequently cultured with (b)
or without (a) 1 mM L-NAME. Data are mean þ S.D. of 4 dishes
from one out of three similar experiments. 100% value is
437.8 þ 16.2 pmol/mg microsomal protein.The evolution of P450 in
standard cultures (no L-NAME added) is over-imposed (dotted line,
open circles) for an easy comparison.
C
Fig. 4. Glycogen content of hepatocytes by 24 h of culture (PAS-positive material, magni¢cation 400U). A: Cells isolated and cultured in rou-
tine conditions (see Section 2). B: Hepatocytes were isolated in medium containing 1 mM L-NAME and subsequently cultured in standard me-
dium with no inhibitor added. C: Cells were isolated and cultured in the presence of 1 mM L-NAME. Glycogen levels correspond to a mean
value of 52.2 þ 1.2 (A), 396.7 þ 19.8 (B) and 1250.1 þ 177.2 (C) nmol glucose/mg cell protein.
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the almost complete preservation of initial P450 levels. E⁄-
cient suppression of NO synthesis during isolation and short-
term culture also signi¢cantly improves cell aerobic mitochon-
drial function, ultimately indicated by (i) a full preservation of
the initial glycogen stores of hepatocytes (Fig. 4), and (ii) a
signi¢cant decrease (by a half) of the glycolytic rates initially
determined in standard conditions (not shown).
3.4. Culture survival and maintenance of the P450 holoenzyme
and activity on exposure to L-NAME
Exposure to L-arginine analogs (i.e. L-NAME up to 3 mM)
does not alter culture survival but rather improves it. This is
re£ected by monolayer development and morphology (Fig. 4)
and hepatocyte viability and survival at this critical stage of
culture (protein recovered by 24 h of culture is 90% of the
initial inoculum vs. 75% in standard conditions). Preservation
of total P450 is not an artifact simply due to data expression
since the microsomal protein/cell protein ratio in cultures ex-
posed for di¡erent times at various L-NAME concentrations
(0.262, r = 0.961) does not di¡er from the ratio obtained in
standard cultures (0.257, r = 0.959). Also, 24-h exposure to L-
NAME does not modify the spectral characteristics of the
P450 holoenzyme recovered (no apparent conversion to
P420) that in these conditions is also catalytically fully active.
TA 5-hydroxylase activity was tested as 2C11-dependent P450
activity (a major isoform in male rat liver). As can be ob-
served (Fig. 5) TA hydroxylation rates determined in hepato-
cytes after 24 h of culture in medium supplemented with L-
NAME (= 1 mM) are close to those obtained in freshly iso-
lated cells when either referred per nmol P450 or per mg cell
protein.
4. Discussion
Arginine-derived NO is a highly versatile signalling mole-
cule involved in the regulation of a variety of cellular func-
tions in di¡erent mammalian cell types (for review see [15^
17]). Hemoproteins and proteins containing non-haem iron or
iron-sulfur complexes are key molecular targets for the radical
within the cells. Its lipophilic nature together with a very short
half-life explains the special susceptibility of membrane-bound
enzymes to locally generated NO. P450, a major class of
haem-containing proteins in liver cells, has also been identi¢ed
as a main target for NO action. As demonstrated in diverse
cellular and subcellular systems exposed to either exogenous
or cell-generated NO [18^21], irreversible loss of P450 involves
haem-nitrosylation followed by haem loss and degradation
which leads to signi¢cant decrease of P450 content and activ-
ity. In liver cells, NO was also shown to inhibit three iron-
containing mitochondrial enzymes (aconitase of the citric-acid
cycle and complexes I and II of the electron transport chain),
thus impairing mitochondrial function [22,23]. NO also inac-
tivates glyceraldehyde-3-phosphate dehydrogenase [24], which
may lead to inhibition of the glycolytic/gluconeogenic path-
ways. Though liver apparently lacks signi¢cant constitutive
NOS activity, both hepatocytes and non-parenchymal cells
(Kup¡er and endothelial) can be induced for iNOS activity
[17,25,26]. In fact, di¡erent studies implicate NO as a key
signal on the alterations of glucose homeostasis (i.e. inhibition
of liver gluconeogenesis [27,28] and stimulation of glycogenol-
ysis [29]) and on the generalized suppression of hepatic drug
metabolism [19] associated with endotoxemia, septic shock
and in£ammation. Studies on hepatocytes from di¡erent spe-
cies including humans [30^34] point to a direct role of hepa-
tocyte-derived NO as a mediator of the cytokine-induced
down-regulation of both expression and activitiy of speci¢c
CYP forms. In these conditions, NO impairs hepatocyte
P450 function by irreversible destruction of the preexisting
enzymes [18^21] but also inhibits the synthesis of new P450
molecules by decreasing CYP genes transcription and mRNA
translation of either constitutive or inducible P450 isoforms
[30,32^34].
Results here reported clearly demonstrate that unstimulated
parenchymal cells isolated from control animals spontane-
ously produce high amounts of NO. NO synthesis parallels
the irreversible loss of total P450 and also the impairment of
the aerobic mitochondrial/glucose metabolism consistently ob-
served at this stage. All of these e¡ects can be easily explained
by NO interaction with liver iron-containing enzymes. Gener-
ation of NO is clearly dependent on hepatocyte NOS activity,
since addition of NOS inhibitors e⁄ciently blocks NO forma-
tion. A direct relation of NO to the phenotypic changes de-
scribed is also demonstrated by the fact that (i) loss of P450
correlates well with NO32 accumulation, with a maximal del-
eterious e¡ect observed when nitrite in the medium reached
about 10 WM, a physiologically signi¢cant level, that is al-
ready achieved by 6^8 h of culture; (ii) metabolic impairment
of hepatocytes is also ascribed to this same period, i.e. the
stages of monolayer development; and (iii) inhibition of NO
synthesis is enough to completely prevent both early P450 loss
and cell energy metabolism alteration (ultimately re£ected by
complete glycogen depletion) in culture.
Hepatocyte endogenous NOS activity is not merely a cell
culture artifact since the level of nitrites in the medium
(149.1 þ 23.5 nmol/mg cell protein after the ¢rst 24 h) is
very signi¢cant and in the range of those produced by hep-
atocytes from di¡erent species following iNOS induction with
endotoxin or proin£ammatory cytokines (60^350 nmol/mg
cell protein [26,30,31] by 24 h of exposure, depending on
the study). Studies on the role of cytokines on hepatocyte
iNOS induction are, however, often performed after an initial
24-h culture period needed for metabolic ‘stabilization’ of
freshly isolated cells. Interestingly, the few studies ascribed
to the ¢rst 24 culture hours [35^37] show a signi¢cant basal
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Fig. 5. Tienilic acid 5-hydroxylation rates by rat hepatocytes after
24 h of culture in the presence of variable amounts of L-NAME.
Data are expressed per nmol P450 or per mg cell protein as indi-
cated, and correspond to mean þ S.D. of 3 dishes from one repre-
sentative experiment. Initial rates (freshly isolated hepatocytes, n = 3
di¡erent preparations) are: 396.2 þ 56.7 pmol 5-OHTA/min/nmol
P450 and 26.5 þ 15.0 pmol 5-OHTA/min/mg cell protein.
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NOS activity (with nitrites in the medium reaching 40^107
nmol/mg cell protein) as compared to basal activity in the
second 24^48-h period (6^18 nmol nitrites/mg cell protein
[26,30,31] or 8 nmol/mg cell protein for this study, not
shown). Whether NO synthesis results from constitutive
NOS or the activity is due to a low level of induction (as
suggests the time-course accumulation of nitrites in the me-
dium) remains to be elucidated. Nevertheless, our results in-
dicate that activation of NO synthesis is a very early event
inherent to hepatocyte isolation and culture in standard con-
ditions. Other signals (apart from cytokines) should be invar-
iably present during the collagenase perfusion or the early
culture steps and may also play a role as stimuli for either
NOS activation or iNOS induction. This may include contam-
inants of commercial collagenases, intra-extracellular calcium
movements (as Ca2-chelation and replacement is a part of
the isolation procedure), oxidative stress [38] or even peptides
derived from extracellular matrix components (laminin, colla-
gen, ¢bronectin) recently described as e⁄cient inducers of
iNOS in human lymphomononuclear cells [39].
In conclusion, this study establishes that accelerated P450
degradation in rat hepatocyte primary cultures is directly re-
lated to endogenous NO overproduction, systematically de-
tected at the stages of monolayer development in standard
cultures. Supplementation of perfusion and culture media
with inhibitors of NO biosynthesis thus provides a very simple
method to avoid this phenomenon. As arginine supply plays a
crucial role on the post-transcriptional regulation of NOS
activity [15^17], concentration of L-arginine in the culture ^
which varies considerably depending on the medium, i.e. from
0.2 mM for Williams E to 2.9 mM for Leibowitz L15 ^ should
be considered when establishing the concentration of the in-
hibitor to be added. This should be high enough to e⁄ciently
block NO formation without a¡ecting arginine requirements
for protein, amino acid and urea synthesis. In our culture
conditions 1 mM L-NAME (also 1 mM aminoguanidine,
not shown), although not su⁄cient for complete suppression
of NO biosynthesis, seems enough for full preservation of
P450 to levels equivalent to those of the intact liver. After
24 h of in vitro exposure to the inhibitor, the P450 recovered
is catalytically fully active and we did not detect any cellular
damage (in fact exposure to L-NAME ameliorated cell mono-
layer development and morphology). The mechanism under-
lying NO interaction with P450 suggests that NO is a non-
speci¢c inactivator of these hemoproteins but, through di¡er-
ences in haem accessibility, NO may well di¡erentially a¡ect
constitutive or inducible P450 isoforms. Our study focused on
constitutively expressed P450 2C11. Studies aimed to evaluate
if NO synthesis inhibition does maintain the relative P450
pattern of the intact liver (from either control or induced
rats) in culture are anticipated.
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